Vimarsana
Biggest News Aggregation in the World

Page 17 - Kkr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kkr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kkr Today - Breaking & Trending Today

KKR pledges telecom tower investment for Philippines - Vimarsana News

KKR pledges telecom tower investment for Philippines

Private equity firm KKR & Co will invest US$400 million in telecoms tower operations in the Philippines, according to an announcement made by the US Department of Commerce this week.

Mdf Commerce To Be Acquired By Funds Managed By KKR - Vimarsana News

Mdf Commerce To Be Acquired By Funds Managed By KKR

Mdf commerce inc. (MDF.TO) has entered into an arrangement agreement to be acquired by funds managed by KKR in an all-cash deal. Upon completion, mdf commerce will become a privately held company.

Healthium: KKR, Carlyle and EQT among five buyout funds in race for Healthium - Vimarsana News

Healthium: KKR, Carlyle and EQT among five buyout funds in race for Healthium

KKR, Carlyle, EQT, Hillhouse, and TA Associates are competing to acquire Healthium Medtech, the largest homegrown surgical sutures and surgical needles manufacturer in India. Apax Partners currently owns 99.8% of Healthium. The company has a significant international presence and moderate client concentration risk.

Simon & Schuster Canada publisher departs months after executive shakeup - Vimarsana News

Simon & Schuster Canada publisher departs months after executive shakeup

S&S’s global chief executive Jonathan Karp did not provide reasons for Kevin Hanson’s exit or name an immediate successor

JB Pharma KKR stake sale: KKR considers selling stake in India's $3 billion JB Pharma - Vimarsana News

JB Pharma KKR stake sale: KKR considers selling stake in India's $3 billion JB Pharma

KKR & Co. is reportedly considering selling its 53.8% controlling stake in Indian pharmaceutical company JB Chemicals & Pharmaceuticals Ltd. The US private equity firm is said to be exploring options and seeking financial advisers for a potential sale, with other buyout firms and industry players expressing preliminary interest. JB Pharma's shares have seen a 68% increase in the past year, valuing the company at just over $3 billion.